Search results for "infarction"

showing 10 items of 1208 documents

Microvascular obstruction in the right ventricle in reperfused anterior myocardial infarction: macroscopic and pathologic evidence in a swine model

2013

medicine.medical_specialtybusiness.industryH&E stainInfarctionAnterior myocardial infarctionmedicine.diseasemedicine.anatomical_structureReperfusion therapyBalloon occlusionVentricleEdemaInternal medicinemedicineCardiologyVentricular volumemedicine.symptomCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Letter by Sacha and Feusette Regarding Article, “Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing M…

2018

We have read with a great interest the article by Fernandez-Jimenez et al presenting a bimodal edematous reaction of reperfused myocardium after ST-segment elevation myocardial infarction (STEMI).1 According to the study, the initial edema emerges early and disappears by 24 hours; however, the second edema appears between days 4 and 7 after reperfusion. The authors conclude that the assessment of …

medicine.medical_specialtybusiness.industryHuman heart030204 cardiovascular system & hematologymedicine.diseaseArea at risk03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineEdemamedicineCardiologycardiovascular diseases030212 general & internal medicineMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

0053: Incidence of cardiovascular events following myocardial infarction in France: an observational analysis using a claims database

2016

Objectives To describe the characteristics and treatments of patients having a myocardial infarction (MI) and estimate the incidence of cardiovascular events following the index MI, in the French Health Insurance database. Method A cohort of patients who had a MI in France between 2007 and 2011 was extracted from a claim database: the Echantillon Generaliste de Beneficiaires (a 1% representative sample of subjects covered by the general health insurance (?600,000 patients). The incidence of cardiovascular events following the index MI was estimated using the Kaplan Meier method. Results 1,977 subjects were identified with an index myocardial MI: 2/3 were males, mean age=67.2 y, 20.6% had di…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.diseaseClopidogrelSurgeryDiabetes mellitusInternal medicineCohortmedicineCumulative incidenceMyocardial infarctionCardiology and Cardiovascular MedicinebusinessStrokeThiazidemedicine.drugArchives of Cardiovascular Diseases Supplements
researchProduct

Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial/Midshaft Lesions in Unprotecte…

2014

Objectives The aim of this study was to report the long-term clinical outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for ostial/midshaft lesions in an unprotected left main coronary artery (ULMCA). Background Data regarding outcomes in these patients are limited. Methods Of a total of 2,775 patients enrolled in the DELTA multinational registry, 856 patients with isolated ostial/midshaft lesions in an ULMCA treated by PCI with DES (n = 482) or CABG (n = 374) were analyzed. Results At a median follow-up period of 1,293 days, there were no significant differences in the propensity score-adjusted analyses for …

medicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.medical_treatmentHazard ratioPercutaneous coronary interventionEuroSCOREmedicine.diseaseConfidence intervalSurgerymedicine.anatomical_structureInternal medicineConventional PCImedicineCardiologyMyocardial infarctionbusinessCardiology and Cardiovascular MedicineArteryJACC-Cardiovascular interventions
researchProduct

Diffusionsgewichtetes MRT bei vertebrobasil�ren Isch�mien

2004

The aim of this study was to evaluate the applicability, sensitivity, and predictive power of diffusion-weighted MR imaging (DWI) in the diagnosis of vertebrobasilar infarction. From 1997 to 2002, we prospectively recruited 268 patients with acute signs and symptoms suspective of vertebrobasilar ischemia. The patients underwent biplanar EPI-T2 and EPI DWI within 24 h after onset of symptoms and high-resolution MRI as a control within 7 days. One hundred twenty-one patients had additional CT scanning. The DWI revealed acute vertebrobasilar infarction in 71.0%. The mean time exposure of DWI was 8 min and thus no more than that of CT imaging. It showed significantly more acute lesions than CT …

medicine.medical_specialtybusiness.industryInfarctionSigns and symptomsGeneral Medicinemedicine.diseaseMr imagingAcute ischemiaSurgeryPsychiatry and Mental healthNeurologyVertebrobasilar ischemiaMedicineCerebellar infarctionIn patientcardiovascular diseasesNeurology (clinical)RadiologyCt imagingbusinessDer Nervenarzt
researchProduct

Platelet Function Changes In Acute Myocardial Infarction

1981

Whether the thrombotic component of myocardial infarction is primary or secondary in a given patient, platelet function alterations can influence many mechanism from which depends if the thrombotic lesion grows or sends platelet emboli to the smaller myocardial vessels. Recently in some cases of infarction, coronary artery spasm has been demonstrated angiographically; thromboxanes, vasoconstrictive and platelet-aggregating substances, are released by platelets during myocardial ischemia. The local release of these substances may modify the myocardial cell viability and regional blood flow.The aim of the present study was to investigate changes in platelet function in relation to the time in…

medicine.medical_specialtybusiness.industryInternal medicineCardiologyMedicinePlateletMyocardial infarctionbusinessmedicine.diseaseFunction (biology)Oral Presentations
researchProduct

P4550Growth differentiation factor 15 as an integrative biomarker of heart failure in patients with acute myocardial infarction

2019

Abstract Background Growth differentiation factor 15 (GDF15), a stress-responsive cytokine member of the transforming growth factor-β family, is an emerging biomarker in cardiovascular (CV) diseases. GDF15 is weakly expressed in normal condition but increased in pathological situations such as inflammation, oxidative stress, and left ventricular remodeling. Recent data suggest GDF15 as a marker in heart failure (HF). Purpose We aimed to identify the determinants of GDF15 circulating levels in patients admitted for an acute myocardial infarction (AMI). Methods In our prospective study, all consecutive patients admitted from June 2016 to February 2018 for type 1 AMI in the Coronary Care unit …

medicine.medical_specialtybusiness.industryInternal medicineHeart failuremedicineCardiologyBiomarker (medicine)In patientMyocardial infarctionCardiology and Cardiovascular Medicinebusinessmedicine.diseaseEuropean Heart Journal
researchProduct

Protein S deficiency and Heerlen polymorphism in a Polish patient with acute myocardial infarction and previous venous thromboembolism

2013

medicine.medical_specialtybusiness.industryInternal medicinemedicineCardiologyHematologyProtein S deficiencyMyocardial infarctionmedicine.diseasebusinessVenous thromboembolism
researchProduct

Innovative Managed Care May Be Related to Improved Prognosis for Acute Myocardial Infarction Survivors

2021

Background: Mortality following discharge in myocardial infarction survivors remains high. Therefore, we compared outcomes in myocardial infarction survivors participating and not participating in a novel, nationwide managed care program for myocardial infarction survivors in Poland. Methods: We used public databases. We included all patients hospitalized due to acute myocardial infarction in Poland between October 1, 2017 and December 31, 2018. We excluded from the analysis all patients aged <18 years as well as those who died during hospitalization or within 10 days following discharge from hospital. All patients were prospectively followed. The primary end point was defined as death …

medicine.medical_specialtybusiness.industryManaged Care ProgramsMyocardial InfarctionPrognosismedicine.diseaseArticleCoronary artery diseasePercutaneous Coronary InterventionInternal medicinemedicineCardiologyHumansManaged careSurvivorsMyocardial infarctionCardiology and Cardiovascular MedicinebusinessCirculation: Cardiovascular Quality and Outcomes
researchProduct

2020

Background Psoriasis is a frequent chronic inflammatory cytokine‐mediated skin disease and was identified to be an independent risk factor for the occurrence of myocardial infarction (MI). However, data about the impact of psoriasis on mortality and other in‐hospital adverse events in the setting of MI are sparse and inconsistent. Methods and Results The nationwide German inpatient sample of the years 2005 to 2016 was used for statistical analysis. Hospitalized patients with MI were stratified for the presence of psoriasis and the impact of psoriasis on in‐hospital events was investigated. Overall, 3 307 703 patients with MI (37.6% females, 56.8% aged ≥70 years) were treated in Germany (20…

medicine.medical_specialtybusiness.industryMortality rateDisease030204 cardiovascular system & hematologymedicine.disease030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinePsoriasismedicineMyocardial infarctionRisk factorCardiology and Cardiovascular MedicinebusinessJournal of the American Heart Association
researchProduct